Abstract
ADP-ribosylation is an ancient modification of proteins, nucleic acids, and other biomolecules found in all kingdoms of life as well as in certain viruses. The regulation of fundamental (patho)physiological processes by ADP-ribosylation, including the cellular stress response, inflammation, and immune response to bacterial and viral pathogens, has created a strong interest into the study of modification establishment and removal to explore novel therapeutic approaches. Beyond ADP-ribosylation in humans, direct targeting of factors that alter host ADP-ribosylation signaling (e.g., viral macrodomains) or utilize ADP-ribosylation to manipulate host cell behavior (e.g., bacterial toxins) were shown to reduce virulence and disease severity. However, the realization of these therapeutic potentials is thus far hampered by the unavailability of simple, high-throughput methods to study the modification “writers” and “erasers” and screen for novel inhibitors.
Here, we describe a scalable method for the measurement of (ADP-ribosyl)hydrolase activity. The assay relies on the conversion of ADP-ribose released from a modified substrate by the (ADP-ribosyl)hydrolase under investigation into AMP by the phosphodiesterase NudT5 into bioluminescence via a commercially available detection assay. Moreover, this method can be utilized to study the role of nudix- or ENPP-type phosphodiesterases in ADP-ribosylation processing and may also be adapted to investigate the activity of (ADP-ribosyl)transferases. Overall, this method is applicable for both basic biochemical characterization and screening of large drug libraries; hence, it is highly adaptable to diverse project needs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perina D, Mikoc A, Ahel J, Cetkovic H, Zaja R, Ahel I (2014) Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life. DNA Repair (Amst) 23:4–16. https://doi.org/10.1016/j.dnarep.2014.05.003
Mikolcevic P, Hlousek-Kasun A, Ahel I, Mikoc A (2021) ADP-ribosylation systems in bacteria and viruses. Comput Struct Biotechnol J 19:2366–2383. https://doi.org/10.1016/j.csbj.2021.04.023
Juarez-Salinas H, Levi V, Jacobson EL, Jacobson MK (1982) Poly(ADP-ribose) has a branched structure in vivo. J Biol Chem 257(2):607–609
Miwa M, Saikawa N, Yamaizumi Z, Nishimura S, Sugimura T (1979) Structure of poly(adenosine diphosphate ribose): identification of 2′-[1″-ribosyl-2″-(or 3″-)(1‴-ribosyl)]adenosine-5′,5″,5‴-tris(phosphate) as a branch linkage. Proc Natl Acad Sci U S A 76(2):595–599. https://doi.org/10.1073/pnas.76.2.595
Vyas S, Matic I, Uchima L, Rood J, Zaja R, Hay RT, Ahel I, Chang P (2014) Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat Commun 5:4426. https://doi.org/10.1038/ncomms5426
Luscher B, Ahel I, Altmeyer M, Ashworth A, Bai P, Chang P, Cohen M, Corda D, Dantzer F, Daugherty MD, Dawson TM, Dawson VL, Deindl S, Fehr AR, Feijs KLH, Filippov DV, Gagne JP, Grimaldi G, Guettler S, Hoch NC, Hottiger MO, Korn P, Kraus WL, Ladurner A, Lehtio L, Leung AKL, Lord CJ, Mangerich A, Matic I, Matthews J, Moldovan GL, Moss J, Natoli G, Nielsen ML, Niepel M, Nolte F, Pascal J, Paschal BM, Pawlowski K, Poirier GG, Smith S, Timinszky G, Wang ZQ, Yelamos J, Yu X, Zaja R, Ziegler M (2021) ADP-ribosyltransferases, an update on function and nomenclature. FEBS J. https://doi.org/10.1111/febs.16142
Suskiewicz MJ, Palazzo L, Hughes R, Ahel I (2021) Progress and outlook in studying the substrate specificities of PARPs and related enzymes. FEBS J 288(7):2131–2142. https://doi.org/10.1111/febs.15518
Luscher B, Butepage M, Eckei L, Krieg S, Verheugd P, Shilton BH (2018) ADP-ribosylation, a multifaceted posttranslational modification involved in the control of cell physiology in health and disease. Chem Rev 118(3):1092–1136. https://doi.org/10.1021/acs.chemrev.7b00122
Crawford K, Bonfiglio JJ, Mikoc A, Matic I, Ahel I (2018) Specificity of reversible ADP-ribosylation and regulation of cellular processes. Crit Rev Biochem Mol Biol 53(1):64–82. https://doi.org/10.1080/10409238.2017.1394265
Palazzo L, Mikolcevic P, Mikoc A, Ahel I (2019) ADP-ribosylation signalling and human disease. Open Biol 9(4):190041. https://doi.org/10.1098/rsob.190041
Schuller M, Ahel I (2022) Beyond protein modification: the rise of non-canonical ADP-ribosylation. Biochem J 479(4):463–477. https://doi.org/10.1042/BCJ20210280
Groslambert J, Prokhorova E, Ahel I (2021) ADP-ribosylation of DNA and RNA. DNA Repair (Amst) 105:103144. https://doi.org/10.1016/j.dnarep.2021.103144
Schuller M, Butler RE, Ariza A, Tromans-Coia C, Jankevicius G, Claridge TDW, Kendall SL, Goh S, Stewart GR, Ahel I (2021) Molecular basis for DarT ADP-ribosylation of a DNA base. Nature 596(7873):597–602. https://doi.org/10.1038/s41586-021-03825-4
Cohen MS, Chang P (2018) Insights into the biogenesis, function, and regulation of ADP-ribosylation. Nat Chem Biol 14(3):236–243. https://doi.org/10.1038/nchembio.2568
Rack JG, Morra R, Barkauskaite E, Kraehenbuehl R, Ariza A, Qu Y, Ortmayer M, Leidecker O, Cameron DR, Matic I, Peleg AY, Leys D, Traven A, Ahel I (2015) Identification of a class of protein ADP-ribosylating sirtuins in microbial pathogens. Mol Cell 59(2):309–320. https://doi.org/10.1016/j.molcel.2015.06.013
Aravind L, Zhang D, de Souza RF, Anand S, Iyer LM (2015) The natural history of ADP-ribosyltransferases and the ADP-ribosylation system. Curr Top Microbiol Immunol 384:3–32. https://doi.org/10.1007/82_2014_414
Yoshida T, Tsuge H (2021) Common mechanism for target specificity of protein- and DNA-targeting ADP-ribosyltransferases. Toxins (Basel) 13(1). https://doi.org/10.3390/toxins13010040
Rack JGM, Palazzo L, Ahel I (2020) (ADP-ribosyl)hydrolases: structure, function, and biology. Genes Dev 34(5-6):263–284. https://doi.org/10.1101/gad.334631.119
Bilokapic S, Suskiewicz MJ, Ahel I, Halic M (2020) Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin. Nature 585(7826):609–613. https://doi.org/10.1038/s41586-020-2725-7
Suskiewicz MJ, Zobel F, Ogden TEH, Fontana P, Ariza A, Yang JC, Zhu K, Bracken L, Hawthorne WJ, Ahel D, Neuhaus D, Ahel I (2020) HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. Nature 579(7800):598–602. https://doi.org/10.1038/s41586-020-2013-6
Ueda K, Hayaishi O (1985) ADP-ribosylation. Annu Rev Biochem 54:73–100. https://doi.org/10.1146/annurev.bi.54.070185.000445
Prokhorova E, Agnew T, Wondisford AR, Tellier M, Kaminski N, Beijer D, Holder J, Groslambert J, Suskiewicz MJ, Zhu K, Reber JM, Krassnig SC, Palazzo L, Murphy S, Nielsen ML, Mangerich A, Ahel D, Baets J, O'Sullivan RJ, Ahel I (2021) Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. Mol Cell 81((12):2640–2655 e2648. https://doi.org/10.1016/j.molcel.2021.04.028
Jankevicius G, Ariza A, Ahel M, Ahel I (2016) The toxin-antitoxin system DarTG catalyzes reversible ADP-ribosylation of DNA. Mol Cell 64(6):1109–1116. https://doi.org/10.1016/j.molcel.2016.11.014
Lawaree E, Jankevicius G, Cooper C, Ahel I, Uphoff S, Tang CM (2020) DNA ADP-ribosylation stalls replication and is reversed by RecF-mediated homologous recombination and nucleotide excision repair. Cell Rep 30(5):1373–1384 e1374. https://doi.org/10.1016/j.celrep.2020.01.014
LeRoux M, Srikant S, Teodoro GIC, Zhang T, Littlehale ML, Doron S, Badiee M, Leung AKL, Sorek R, Laub MT (2022) The DarTG toxin-antitoxin system provides phage defence by ADP-ribosylating viral DNA. Nat Microbiol 7(7):1028–1040. https://doi.org/10.1038/s41564-022-01153-5
Rack JG, Perina D, Ahel I (2016) Macrodomains: structure, function, evolution, and catalytic activities. Annu Rev Biochem 85:431–454. https://doi.org/10.1146/annurev-biochem-060815-014935
Rack JGM, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, Reber JM, Krassnig SC, Ahel D, van der Marel GA, Mangerich A, McCullagh JSO, Filippov DV, Ahel I (2021) Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal. Nat Commun 12(1):4581. https://doi.org/10.1038/s41467-021-24723-3
Alvarez-Gonzalez R, Althaus FR (1989) Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents. Mutat Res 218(2):67–74. https://doi.org/10.1016/0921-8777(89)90012-8
Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I (2017) Serine ADP-ribosylation reversal by the hydrolase ARH3. Elife 6. https://doi.org/10.7554/eLife.28533
Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D, Ahel I (2011) The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477(7366):616–620. https://doi.org/10.1038/nature10404
Mashimo M, Kato J, Moss J (2014) Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases. DNA Repair (Amst) 23:88–94. https://doi.org/10.1016/j.dnarep.2014.03.005
Rack JGM, Ariza A, Drown BS, Henfrey C, Bartlett E, Shirai T, Hergenrother PJ, Ahel I (2018) (ADP-ribosyl)hydrolases: structural basis for differential substrate recognition and inhibition. Cell Chem Biol 25(12):1533–1546 e1512. https://doi.org/10.1016/j.chembiol.2018.11.001
Palazzo L, Daniels CM, Nettleship JE, Rahman N, McPherson RL, Ong SE, Kato K, Nureki O, Leung AK, Ahel I (2016) ENPP1 processes protein ADP-ribosylation in vitro. FEBS J 283(18):3371–3388. https://doi.org/10.1111/febs.13811
Palazzo L, Thomas B, Jemth AS, Colby T, Leidecker O, Feijs KL, Zaja R, Loseva O, Puigvert JC, Matic I, Helleday T, Ahel I (2015) Processing of protein ADP-ribosylation by Nudix hydrolases. Biochem J 468(2):293–301. https://doi.org/10.1042/BJ20141554
Hayaishi O, Ueda K (1977) Poly(ADP-ribose) and ADP-ribosylation of proteins. Annu Rev Biochem 46:95–116. https://doi.org/10.1146/annurev.bi.46.070177.000523
Carreras-Puigvert J, Zitnik M, Jemth AS, Carter M, Unterlass JE, Hallstrom B, Loseva O, Karem Z, Calderon-Montano JM, Lindskog C, Edqvist PH, Matuszewski DJ, Ait Blal H, Berntsson RPA, Haggblad M, Martens U, Studham M, Lundgren B, Wahlby C, Sonnhammer ELL, Lundberg E, Stenmark P, Zupan B, Helleday T (2017) A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family. Nat Commun 8(1):1541. https://doi.org/10.1038/s41467-017-01642-w
Grudzien-Nogalska E, Wu Y, Jiao X, Cui H, Mateyak MK, Hart RP, Tong L, Kiledjian M (2019) Structural and mechanistic basis of mammalian Nudt12 RNA deNADding. Nat Chem Biol 15(6):575–582. https://doi.org/10.1038/s41589-019-0293-7
Wu H, Li L, Chen KM, Homolka D, Gos P, Fleury-Olela F, McCarthy AA, Pillai RS (2019) Decapping enzyme NUDT12 partners with BLMH for cytoplasmic surveillance of NAD-capped RNAs. Cell Rep 29(13):4422–4434 e4413. https://doi.org/10.1016/j.celrep.2019.11.108
Abdelraheim SR, Spiller DG, McLennan AG (2003) Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 protein. Biochem J 374(Pt 2):329–335. https://doi.org/10.1042/BJ20030441
Seman M, Adriouch S, Haag F, Koch-Nolte F (2004) Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr Med Chem 11(7):857–872. https://doi.org/10.2174/0929867043455611
Hesse J, Rosse MK, Steckel B, Blank-Landeshammer B, Idel S, Reinders Y, Sickmann A, Strater N, Schrader J (2022) Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity. Purinergic Signal 18(1):115–121. https://doi.org/10.1007/s11302-021-09832-4
Bonfiglio JJ, Fontana P, Zhang Q, Colby T, Gibbs-Seymour I, Atanassov I, Bartlett E, Zaja R, Ahel I, Matic I (2017) Serine ADP-ribosylation depends on HPF1. Mol Cell 65(5):932–940 e936. https://doi.org/10.1016/j.molcel.2017.01.003
Bonfiglio JJ, Leidecker O, Dauben H, Longarini EJ, Colby T, San Segundo-Acosta P, Perez KA, Matic I (2020) An HPF1/PARP1-based chemical biology strategy for exploring ADP-ribosylation. Cell 183(4):1086–1102 e1023. https://doi.org/10.1016/j.cell.2020.09.055
Depaix A, Kowalska J (2019) NAD analogs in aid of chemical biology and medicinal chemistry. Molecules 24(22). https://doi.org/10.3390/molecules24224187
Gibson BA, Conrad LB, Huang D, Kraus WL (2017) Generation and characterization of recombinant antibody-like ADP-ribose binding proteins. Biochemistry 56(48):6305–6316. https://doi.org/10.1021/acs.biochem.7b00670
Leidecker O, Bonfiglio JJ, Colby T, Zhang Q, Atanassov I, Zaja R, Palazzo L, Stockum A, Ahel I, Matic I (2016) Serine is a new target residue for endogenous ADP-ribosylation on histones. Nat Chem Biol 12(12):998–1000. https://doi.org/10.1038/nchembio.2180
Hendriks IA, Buch-Larsen SC, Prokhorova E, Elsborg JD, Rebak A, Zhu K, Ahel D, Lukas C, Ahel I, Nielsen ML (2021) The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome. Nat Commun 12(1):5893. https://doi.org/10.1038/s41467-021-26172-4
Challa S, Stokes MS, Kraus WL (2021) MARTs and MARylation in the cytosol: biological functions, mechanisms of action, and therapeutic potential. Cells 10(2):doi:10.3390/cells10020313
Fu W, Yao H, Butepage M, Zhao Q, Luscher B, Li J (2021) The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation. Drug Discov Today 26(11):2547–2558. https://doi.org/10.1016/j.drudis.2021.05.007
O’Sullivan J, Tedim Ferreira M, Gagne JP, Sharma AK, Hendzel MJ, Masson JY, Poirier GG (2019) Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation. Nat Commun 10(1):1182. https://doi.org/10.1038/s41467-019-08859-x
Rack JGM, Zorzini V, Zhu Z, Schuller M, Ahel D, Ahel I (2020) Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biol 10(11):200237. https://doi.org/10.1098/rsob.200237
Voorneveld J, Rack JGM, Ahel I, Overkleeft HS, van der Marel GA, Filippov DV (2018) Synthetic alpha- and beta-Ser-ADP-ribosylated peptides reveal alpha-Ser-ADPr as the native epimer. Org Lett 20(13):4140–4143. https://doi.org/10.1021/acs.orglett.8b01742
Minnee H, Rack JGM, van der Marel GA, Overkleeft HS, Codee JDC, Ahel I, Filippov DV (2022) Mimetics of ADP-ribosylated histidine through copper(I)-catalyzed click chemistry. Org Lett. https://doi.org/10.1021/acs.orglett.2c01300
Voorneveld J, Rack JGM, van Gijlswijk L, Meeuwenoord NJ, Liu Q, Overkleeft HS, van der Marel GA, Ahel I, Filippov DV (2021) Molecular tools for the study of ADP-ribosylation: a unified and versatile method to synthesise native mono-ADP-ribosylated peptides. Chemistry 27(41):10621–10627. https://doi.org/10.1002/chem.202100337
Kasson S, Dharmapriya N, Kim IK (2021) Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes. PLoS One 16(6):e0254022. https://doi.org/10.1371/journal.pone.0254022
Dasovich M, Zhuo J, Goodman JA, Thomas A, McPherson RL, Jayabalan AK, Busa VF, Cheng SJ, Murphy BA, Redinger KR, Alhammad YMO, Fehr AR, Tsukamoto T, Slusher BS, Bosch J, Wei H, Leung AKL (2022) High-throughput activity assay for screening inhibitors of the SARS-CoV-2 Mac1 macrodomain. ACS Chem Biol 17(1):17–23. https://doi.org/10.1021/acschembio.1c00721
Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Strom CE, Svensson LM, Schultz N, Lundback T, Einarsdottir BO, Saleh A, Gokturk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Stromberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Brautigam L, Johansson L, Hoglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KS, Wallner OA, Hammarstrom LG, Wiita E, Almlof I, Kalderen C, Axelsson H, Djureinovic T, Puigvert JC, Haggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jensen AJ, Artursson P, Nilsson JA, Stenmark P, Scobie M, Berglund UW, Helleday T (2014) MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature 508(7495):215–221. https://doi.org/10.1038/nature13181
Dunn CA, O'Handley SF, Frick DN, Bessman MJ (1999) Studies on the ADP-ribose pyrophosphatase subfamily of the nudix hydrolases and tentative identification of trgB, a gene associated with tellurite resistance. J Biol Chem 274(45):32318–32324. https://doi.org/10.1074/jbc.274.45.32318
Sharifi R, Morra R, Appel CD, Tallis M, Chioza B, Jankevicius G, Simpson MA, Matic I, Ozkan E, Golia B, Schellenberg MJ, Weston R, Williams JG, Rossi MN, Galehdari H, Krahn J, Wan A, Trembath RC, Crosby AH, Ahel D, Hay R, Ladurner AG, Timinszky G, Williams RS, Ahel I (2013) Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J 32(9):1225–1237. https://doi.org/10.1038/emboj.2013.51
Gibbs-Seymour I, Fontana P, Rack JGM, Ahel I (2016) HPF1/C4orf27 Is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity. Mol Cell 62(3):432–442. https://doi.org/10.1016/j.molcel.2016.03.008
Langelier MF, Planck JL, Servent KM, Pascal JM (2011) Purification of human PARP-1 and PARP-1 domains from Escherichia coli for structural and biochemical analysis. Methods Mol Biol 780:209–226. https://doi.org/10.1007/978-1-61779-270-0_13
Kistemaker HA, Nardozza AP, Overkleeft HS, van der Marel GA, Ladurner AG, Filippov DV (2016) Synthesis and macrodomain binding of mono-ADP-ribosylated peptides. Angew Chem Int Ed Engl 55(36):10634–10638. https://doi.org/10.1002/anie.201604058
Bartlett E, Bonfiglio JJ, Prokhorova E, Colby T, Zobel F, Ahel I, Matic I (2018) Interplay of histone marks with serine ADP-ribosylation. Cell Rep 24(13):3488–3502 e3485. https://doi.org/10.1016/j.celrep.2018.08.092
Nielsen PE (2004) Peptide nucleic acids : protocols and applications, 2nd edn. Horizon Scientific, Wymondham
Acknowledgments
The authors would like to thank Dmitri Filippov (Leiden Institute of Chemistry, University of Leiden, the Netherlands) for providing chemical probes that established this method, Marion Schuller (Sir William Dunn School of Pathology, University of Oxford, UK) for advice and technical assistance in establishing this method for the study of DNA modifications, and Roberto Raggiaschi and Rebecca Smith for critical comments on the manuscript. Work in the laboratory of I.A. is supported by the Wellcome Trust (grant number 210634), BBSRC (BB/R007195/1), Ovarian Cancer Research Alliance (Collaborative Research Development Grant #813369), and Cancer Research UK (C35050/A22284).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rack, J.G.M., Ahel, I. (2023). A Simple Method to Study ADP-Ribosylation Reversal: From Function to Drug Discovery. In: Tulin, A.V. (eds) Poly(ADP-Ribose) Polymerase. Methods in Molecular Biology, vol 2609. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2891-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2891-1_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2890-4
Online ISBN: 978-1-0716-2891-1
eBook Packages: Springer Protocols